Business Context and Reporting Period
Company: TON Strategy Company (TONX)
Filing Type: Form 8-K (Current Report)
Date of Report: June 18, 2026
Reporting Period: Specific event date of June 18, 2026
The filing addresses a regulatory matter with The Nasdaq Stock Market LLC regarding a violation of shareholder approval requirements under Nasdaq Listing Rule 5635(c).
Key Financial Metrics
This Form 8-K is a current report regarding a corporate governance and listing compliance matter. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data.
Material Changes and Events
- Regulatory Action: On June 18, 2026, the Company received a Letter of Reprimand from Nasdaq staff.
- Cause of Violation: The Company inadvertently issued equity awards (Excess Awards) under the 2019 Stock and Incentive Compensation Plan in excess of the amount available without prior shareholder approval.
- Self-Reporting: The Company voluntarily notified Nasdaq of the potential violation on March 27, 2026.
- Remediation: The Company obtained subsequent shareholder ratification for sufficient shares to cover prior grants and rescinded recent grants to officers and directors.
- Outcome: Nasdaq determined the failure was not deliberate. The Company's securities will remain listed on Nasdaq, and the matter is considered closed.
Guidance, Outlook, and Risks
Management Commentary: The Company accepts the Staff's determination and considers the matter closed. No further action is required from the Company regarding this specific issue.
Future Commitments: The Company has committed to working with Nasdaq to ensure future compliance with Listing Rules.
Risks: The filing highlights the risk of inadvertent violations of listing rules regarding equity compensation plans. However, the risk of delisting for this specific event has been mitigated by the issuance of the Reprimand Letter rather than a delisting notice.
Investor Verification Checklist
- Verify the status of the 2019 Stock and Incentive Compensation Plan to ensure no further excess awards have been issued.
- Confirm that the rescinded grants to officers and directors have been formally processed and documented.
- Review the Company's internal controls over equity compensation administration to prevent recurrence.
- Check for any subsequent correspondence from Nasdaq regarding the Company's compliance commitments.